Codeine linctus to be reclassified to POM status over 'risk of abuse'
Codeine linctus is set to be reclassified from a pharmacy (P) medicine to prescription-only medicine (POM) status, the medicines regulator has announced.
The Medicines and Healthcare products Regulatory Agency (MHRA) today (February 20) saidit will reclassify codeine linctus, an oral solution or syrup licensed to treat